Literature DB >> 7956396

Decreased heart rate variability in patients with chronic obstructive pulmonary disease.

M Volterrani1, S Scalvini, G Mazzuero, P Lanfranchi, R Colombo, A L Clark, G Levi.   

Abstract

To evaluate possible autonomic nervous system (ANS) dysfunction in patients with chronic obstructive pulmonary disease (COPD) in the absence of any hypoxic neuronal damage, we studied 31 patients with COPD patients aged 31 to 68 years (55 +/- 10) and 32 age-matched healthy subjects (control). Respiratory function in the patients was as follows: FEV1 = 52 +/- 8 percent; PaO2 = 71 +/- 14 mm Hg; and PaCO2 = 40 +/- 10 mm Hg. The ANS was assessed by heart rate variability (HRV) in the time domain (SD of mean RR interval) and frequency domain (autoregressive spectral analysis recognizing low [LF] and high [HF] frequency components, vagal and sympathetic related, respectively). Patients and controls were evaluated at rest and during vagal (controlled breathing [CB]) and sympathetic (passive head-up tilt) maneuvers. Patients with COPD showed a depressed global HRV (rest SD = 34 +/- 20 ms vs 45 +/- 15 ms, p < 0.05; tilt SD = 28 +/- 14 ms vs 38 +/- 13, p < 0.01) with a predominant respiratory drive (rest HF = 44 +/- 28 vs 28 +/- 18, p < 0.05; tilt HF 42 +/- 28 vs 16 +/- 12, p < 0.01) as compared with normal subjects. In the control group, vagal and sympathetic responses were in opposite directions following a stimulus, whereas there was no significant HRV response in the COPD group. We conclude that patients with COPD have abnormalities of ANS function, with in particular a depressed HRV response to sympathetic and vagal stimuli.

Entities:  

Mesh:

Year:  1994        PMID: 7956396     DOI: 10.1378/chest.106.5.1432

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  37 in total

1.  Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Fracois Maltais; Yves Lacasse; Yves Lacourciere; Claudette Fortin; Paul Poirier
Journal:  Can Respir J       Date:  2008-10       Impact factor: 2.409

Review 2.  β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.

Authors:  Maria Gabriella Matera; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

3.  Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Arnoldus J R van Gestel; Joerg Steier
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

4.  Increased QT dispersion: a negative prognostic finding in chronic obstructive pulmonary disease.

Authors:  Roberto Zulli; Paolo Donati; Franco Nicosia; Massimiliano De Vecchi; Claudio Tantucci; Giuseppe Romanelli; Vittorio Grassi
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 5.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

6.  Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Authors:  Tufan Tükek; Pinar Yildiz; Vakur Akkaya; Mehmet Akif Karan; Dursun Atilgan; Veysel Yilmaz; Ferruh Korkut
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

7.  Heart rate variability and disease characteristics in patients with COPD.

Authors:  Carlos A Camillo; Fabio Pitta; Heloíse V Possani; Marcus V R A Barbosa; Divina S O Marques; Vinícius Cavalheri; Vanessa S Probst; Antonio F Brunetto
Journal:  Lung       Date:  2008-09-25       Impact factor: 2.584

8.  Deep breathing heart rate variability is associated with respiratory muscle weakness in patients with chronic obstructive pulmonary disease.

Authors:  Michel Silva Reis; Ross Arena; Ana Paula Deus; Rodrigo Polaquini Simões; Aparecida Maria Catai; Audrey Borghi-Silva
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

9.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.

Authors:  D M Mannino; A S Buist; T L Petty; P L Enright; S C Redd
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 10.  Controlled human exposures to ambient pollutant particles in susceptible populations.

Authors:  Yuh-Chin T Huang; Andrew J Ghio
Journal:  Environ Health       Date:  2009-07-25       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.